...
首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects
【24h】

Plasma cholesterol esterase level is a determinant for an atherogenic lipoprotein profile in normolipidemic human subjects

机译:血浆胆固醇酯酶水平是正常血脂人类受试者中动脉粥样硬化脂蛋白谱的决定因素

获取原文
获取原文并翻译 | 示例
           

摘要

Plasma cholesterol level is controlled by various factors. In the present study, high plasma activity of cholesterol esterase was found to correlate with plasma total cholesterol and low density lipoprotein (LDL) cholesterol levels in normolipidemic human subjects. However, the cholesterol esterase is not elevated in plasma of patients with familial hypercholesterolemia. These observations suggest that cholesterol esterase level is not determined by plasma cholesterol level, but elevated cholesterol esterase may be causative in increasing plasma cholesterol and LDL. Additional experiments further demonstrated that cholesterol esterase can convert the larger and less-atherogenic LDL to the smaller and more atherogenic LDL subspecies in vitro. These results suggest that plasma cholesterol esterase contributes to the formation and accumulation of atherogenic lipoproteins, and thus is a major risk factor for premature atherosclerosis in normal human subjects.
机译:血浆胆固醇水平受多种因素控制。在本研究中,胆固醇酯酶的高血浆活性被发现与血脂正常的人类受试者的血浆总胆固醇和低密度脂蛋白(LDL)胆固醇水平相关。但是,家族性高胆固醇血症患者血浆中的胆固醇酯酶并未升高。这些观察结果表明胆固醇酯酶水平不是由血浆胆固醇水平决定的,但胆固醇酯酶升高可能是导致血浆胆固醇和LDL升高的原因。进一步的实验进一步证明,胆固醇酯酶可以在体外将较大且动脉粥样硬化程度较低的LDL亚种转化为较小且动脉粥样硬化程度较低的LDL亚种。这些结果表明血浆胆固醇酯酶有助于动脉粥样硬化脂蛋白的形成和积累,因此是正常人动脉粥样硬化的主要危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号